Use of MIP-1Beta inhibitors for improving angiogenesis to reduce tissue ischemia and rescue diabetic vascular disease in diabetes mellitus

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15521153

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a use of MIP-1β inhibitor for promoting angiogenesis in diabetes mellitus patients so as to improve tissue ischemia in damaged area and to prevent diabetic vasculopathy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NATIONAL YANG-MING UNIVERSITYTAIPEI CITY 112 TAIWAN (ROC)
TAIPEI VETERANS GENERAL HOSPITALNO 201 SEC 2 SHIPAI RD BEITOU DIST TAIPEI CITY 11217

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CHANG, Ting-Ting Taipei, TW 18 23
CHEN, Jaw-Wen Taipei, TW 10 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation